COVID-19, Social Distancing, and Cognitive Impairment in 1Florida ADRC participants
COVID-19, Social Distancing, and Cognitive Impairment in 1Florida ADRC participants
批准号:
10194967
负责人:
Todd E Golde
金额:
$15.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-15 至 2025-04-30
关键词:
2019-nCoVAffectAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease patientAlzheimer&aposs disease related dementiaBehaviorCOVID-19COVID-19 pandemicCaregiversClinicalCognitionCognitiveCollaborationsCommunicationCultural DiversityDementiaDependenceDiseaseElderlyEpidemicEvaluationFamilyFloridaGenetic VariationHealthHispanicsImpaired cognitionIncidenceIndividualInstitutionInternationalInterventionLewy Body DementiaLinguisticsMedical centerMinorityMissionMoodsNot Hispanic or LatinoOutcomeParticipantPatientsPersonal SatisfactionPopulationPopulation HeterogeneityReadinessReportingResearch PersonnelSARS coronavirusSeveritiesSocial DistanceSocial isolationSocial supportStressSupport GroupsTechnologyTelecommunicationsUnderrepresented MinorityUnited StatesUniversitiesVascular DiseasesWorkaccurate diagnosiscohortcomorbiditycoronavirus diseaseethnic diversityfollow-uphigh riskhuman old age (65+)interestlow socioeconomic statuspandemic diseasepreventprogramspsychosocialracial diversityrecruittelehealth
中文摘要
约56万阿尔茨海默病(AD)患者和400万居民
年了,佛罗里达州将继续成为美国AD疫情的震中
各州。佛罗里达州ADRC是佛罗里达州各机构之间的合作项目,
包括佛罗里达大学(UF),Mt.迈阿密海滩的西奈医疗中心
(MSMC)、迈阿密大学(UM)、佛罗里达国际大学(FIU)和佛罗里达
大西洋大学(FAU)。1佛罗里达ADRC的全球使命是与其他
ADRC和AD利益相关者改变对AD及其相关的理解
痴呆(ADRD)因此可以更快、更准确地诊断AD+ADRD,更多
有效治疗,并最终预防或治愈。多项研究表明,
西班牙裔和其他代表性不足的少数族裔中痴呆症的发病率较高
种群(URM)。我们成功地招募和评估了大多数西班牙裔
队列已使我们能够开始评估是否存在差异
南佛罗里达州拉美裔和非拉美裔之间的AD+ADRD。增强我们的
了解不同民族和种族人群中的痴呆症是一个主要的
我们亚洲发展研究中心的主题。SARS-CoV-2或严重急性呼吸综合征
2型冠状病毒(新冠肺炎)的大流行可能对
阿尔茨海默病认知障碍患者的健康和幸福感
疾病及相关障碍(ADRD)。我们相信这场大流行已经把我们的
临床核心队列,实际上是所有受AD+ADRD影响的家庭
压力。在本增刊中,我们将利用我们成功的机构和研究人员
进一步扩大我们的接触和纵向后续行动的伙伴关系
具有种族、语言、文化和遗传多样性的参与者,以及
与阿尔茨海默病相关的并发症(如血管疾病、路易体痴呆
(LBD))。本附录的具体目的是考察:1)社会影响
新冠肺炎引起的隔离应激对情绪、功能、行为和行为的影响
认知状况2)认知障碍严重程度对社交距离的影响
行为。3)视频通信的使用范围和熟练程度
技术4)参与电信业务的兴趣程度
通过视频在参与者中提供支持性小组计划
通信技术接入。
英文摘要
With ~560,000 Alzheimer’s disease (AD) patients and >4 million residents >65
years old, Florida will continue to be, an epicenter of the AD epidemic in the United
States. The 1Florida ADRC is a collaboration between Florida institutions,
including the University of Florida (UF), Mt. Sinai Medical Center in Miami Beach
(MSMC), University of Miami (UM), Florida International University (FIU), and Florida
Atlantic University (FAU). The 1Florida ADRC’s global mission is to work with other
ADRCs and AD stakeholders to change the understanding of AD and related
dementias (ADRDs) so AD+ADRDs are more quickly and accurately diagnosed, more
effectively treated, and ultimately prevented or cured. Multiple studies suggest a
higher incidence of dementia among Hispanics and other underrepresented minority
populations (URM). Our successful recruitment and evaluation of a majority Hispanic
cohort has enabled us to begin to evaluate whether there are differences in
AD+ADRDs between Hispanics and non-Hispanics in South Florida. Enhancing our
understanding of dementia in ethnically and racially diverse populations is a major
theme of our ADRC. The SARS-CoV-2 or severe acute respiratory syndrome
coronavirus type 2 (COVID-19) pandemic could prove especially detrimental to the
health and well-being of individuals with cognitive impairment due to Alzheimer’s
disease and related disorders (ADRD). We believe this pandemic has placed our
clinical core cohort and indeed all families affect by AD+ADRD under a great deal of
stress. In this supplement, we will leverage our successful institutional and investigator
partnerships to further expand our engagement and longitudinal follow up of
participants with ethnic, linguistic, cultural, and genetic diversity, as well as
comorbidities associated with AD (e.g., vascular disease, Lewy Body Dementia
(LBD)). The specific aims of this supplement are to examine: 1) Effects of social
isolation stress as a result of COVID-19 on mood, function, behavior and
cognitive status 2) Effects of cognitive impairment severity on social distancing
behaviors. 3) Extent of access and proficiency with video communications
technologies 4) Extent of interest in participation in a telecommunications
delivered supportive group program among those participants with video
communications technology access.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Amyloidosis associated proteins in Alzheimer’s disease pathogenesis
-
批准号:10317235
-
项目类别:
-
资助金额:$229.01万
-
财政年份:2021
-
负责人:Todd E Golde
-
依托单位:
1Florida Alzheimer's Disease Research Center
-
批准号:10190771
-
项目类别:
-
资助金额:$298.72万
-
财政年份:2020
-
负责人:Todd E Golde
-
依托单位:
1Florida Alzheimer's Disease Research Center Administrative Core
-
批准号:10190772
-
项目类别:
-
资助金额:$18.35万
-
财政年份:2020
-
负责人:Todd E Golde
-
依托单位:
1Florida Alzheimer's Disease Research Center Administrative Core
-
批准号:9921602
-
项目类别:
-
资助金额:$54.78万
-
财政年份:2020
-
负责人:Todd E Golde
-
依托单位:
1Florida Alzheimer's Disease Research Center
-
批准号:9921600
-
项目类别:
-
资助金额:$303.96万
-
财政年份:2020
-
负责人:Todd E Golde
-
依托单位:
Social Determinants of Health, Race/Ethnicity, and White Matter Hyperintensities
-
批准号:10402153
-
项目类别:
-
资助金额:$5.28万
-
财政年份:2020
-
负责人:Todd E Golde
-
依托单位:
1Florida Alzheimer's Disease Research Center
-
批准号:10640412
-
项目类别:
-
资助金额:$7.04万
-
财政年份:2020
-
负责人:Todd E Golde
-
依托单位:
University of Florida - Mt. Sinai Medical Center AD Research Center
-
批准号:8848980
-
项目类别:
-
资助金额:$152.19万
-
财政年份:2015
-
负责人:Todd E Golde
-
依托单位:
University of Florida - Mt. Sinai Medical Center AD Research Center
-
批准号:9293194
-
项目类别:
-
资助金额:$141.37万
-
财政年份:2015
-
负责人:Todd E Golde
-
依托单位:
Project 1
-
批准号:8848986
-
项目类别:
-
资助金额:$17.38万
-
财政年份:2015
-
负责人:Todd E Golde
-
依托单位:
University of Florida - Mt. Sinai Medical Center AD Research Center
-
批准号:9753814
-
项目类别:
-
资助金额:$140.53万
-
财政年份:2015
-
负责人:Todd E Golde
-
依托单位:
University of Florida - Mt. Sinai Medical Center AD Research Center
-
批准号:9120740
-
项目类别:
-
资助金额:$144.95万
-
财政年份:2015
-
负责人:Todd E Golde
-
依托单位:
Profiling y-secretase activity and inhibition
-
批准号:8415153
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2013
-
负责人:Todd E Golde
-
依托单位:
A Systems Approach to Targeting Innate Immunity in AD
-
批准号:9982553
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2013
-
负责人:Todd E Golde
-
依托单位:
Role of Rer1 in the regulation of gamma-secretase trafficking and activity
-
批准号:8048979
-
项目类别:
-
资助金额:$22.86万
-
财政年份:2009
-
负责人:Todd E Golde
-
依托单位:
TARGET IDENTIFICATION AND MECHANISMS OF ACTIONS OF y-SECRETASE MODULATORS
-
批准号:7568357
-
项目类别:
-
资助金额:$46.65万
-
财政年份:2008
-
负责人:Todd E Golde
-
依托单位:
Abeta42 Altering Compounds: Mechanisms of Action
-
批准号:7533387
-
项目类别:
-
资助金额:$53.27万
-
财政年份:2008
-
负责人:Todd E Golde
-
依托单位:
CHEMISTRY CORE
-
批准号:7034747
-
项目类别:
-
资助金额:$12.04万
-
财政年份:2005
-
负责人:Todd E Golde
-
依托单位:
AB AND BEYOND: Y-SECRETASE A DRUG TARGET FOR CNS DISEASE
-
批准号:7034748
-
项目类别:
-
资助金额:$27.73万
-
财政年份:2005
-
负责人:Todd E Golde
-
依托单位:
In situ therapeutic anti-AB delivery/adenoviral vectors
-
批准号:6649205
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2002
-
负责人:Todd E Golde
-
依托单位:
海外基金